These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe. Rose M; Zielen S Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758 [TBL] [Abstract][Full Text] [Related]
4. Management of laboratory test results in family practice. An OKPRN study. Oklahoma Physicians Resource/Research Network. Mold JW; Cacy DS; Dalbir DK J Fam Pract; 2000 Aug; 49(8):709-15. PubMed ID: 10947137 [TBL] [Abstract][Full Text] [Related]
5. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations. Manchikanti L Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710 [TBL] [Abstract][Full Text] [Related]
6. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccine: to vaccinate or to revaccinate--that is the question. Uiterwyk SH Med Health R I; 2004 Mar; 87(3):68-71. PubMed ID: 15085683 [No Abstract] [Full Text] [Related]
8. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
9. [Organizational models of vaccine practices]. Valsecchi M; Napoletano G; Nguyen T; Zivelonghi G Ann Ig; 2002; 14(3 Suppl 3):75-82. PubMed ID: 12389414 [No Abstract] [Full Text] [Related]
10. Adults with invasive pneumococcal disease: missed opportunities for vaccination. Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG; Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452 [TBL] [Abstract][Full Text] [Related]
11. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations. Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076 [TBL] [Abstract][Full Text] [Related]
12. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
13. Modelling the costs and effects of a universal infant immunization program using conjugated pneumococcal vaccine in British Columbia. Moore D; Bigham M; Patrick D Can Commun Dis Rep; 2003 Jun; 29(11):97-104. PubMed ID: 12794969 [No Abstract] [Full Text] [Related]
14. Web-based classroom data collection in ADHD: a best practices case study. Bhatara V; Vogt HB; Ellis R; Alshari G; Patrick S S D J Med; 2003 Sep; 56(9):385-9. PubMed ID: 14524139 [TBL] [Abstract][Full Text] [Related]
15. Tutorials in clinical research: part V: outcomes research. Stewart MG; Neely JG; Hartman JM; Wallace MS; Forsen JW Laryngoscope; 2002 Feb; 112(2):248-54. PubMed ID: 11889379 [TBL] [Abstract][Full Text] [Related]
16. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine. National Advisory Committee on Immunization Can Commun Dis Rep; 2002 Jan; 28(ACS-2):1-32. PubMed ID: 12728645 [No Abstract] [Full Text] [Related]